Yang Guobiao, Yang Wanying
Department of Physical Education, Xidian University, Xi'an, Shaanxi, China.
School of Marxism, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Front Mol Biosci. 2025 May 20;12:1587124. doi: 10.3389/fmolb.2025.1587124. eCollection 2025.
The intricate interplay between physical training and non-coding RNAs, specifically microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), has attracted considerable attention in understanding physiological adaptations and pathological conditions. Both miRNAs and lncRNAs are essential modulators of gene expression, influencing various cellular processes, including those related to muscle metabolism, inflammation, and recovery from injury. This review investigates the bifunctional role of miRNAs and lncRNAs in response to physical training, highlighting their involvement in muscle hypertrophy, endurance adaptations, and the modulation of inflammatory pathways. Additionally, we examine how pathological conditions, such as cardiovascular disease, heart failure, can alter the expression profiles of miRNAs and lncRNAs, potentially disrupting the beneficial effects of physical training. The crosstalk between these non-coding RNAs under physiological and pathological states underscores their potential as biomarkers for assessing training responses and therapeutic targets for enhancing recovery and performance. Understanding these interactions may pave the way for novel interventions to optimize health outcomes through tailored physical training programs.
体育锻炼与非编码RNA(特别是微小RNA(miRNA)和长链非编码RNA(lncRNA))之间复杂的相互作用,在理解生理适应和病理状况方面引起了相当大的关注。miRNA和lncRNA都是基因表达的重要调节因子,影响各种细胞过程,包括与肌肉代谢、炎症和损伤恢复相关的过程。本综述研究了miRNA和lncRNA在应对体育锻炼时的双重作用,强调它们在肌肉肥大、耐力适应以及炎症途径调节中的作用。此外,我们还研究了诸如心血管疾病、心力衰竭等病理状况如何改变miRNA和lncRNA的表达谱,从而可能破坏体育锻炼的有益效果。这些非编码RNA在生理和病理状态下的相互作用突显了它们作为评估训练反应的生物标志物以及增强恢复和表现的治疗靶点的潜力。了解这些相互作用可能为通过量身定制的体育锻炼计划优化健康结果的新型干预措施铺平道路。
J Appl Physiol (1985). 2018-12-20
J Sport Health Sci. 2018-10
ESC Heart Fail. 2015-9
Adv Exp Med Biol. 2020
Clin Exp Med. 2025-7-6
J Cardiothorac Surg. 2025-1-15
Front Cardiovasc Med. 2024-11-1
Cell. 2024-11-14
Rev Cardiovasc Med. 2023-9-6
Int J Mol Sci. 2024-7-8
Mol Ther Nucleic Acids. 2024-5-24
Int J Mol Sci. 2024-6-1
Front Endocrinol (Lausanne). 2024